Switching from Byetta to Wegovy or Zepbound: Why Many Patients Are Transitioning to Newer GLP-1 Therapies
Patients using older GLP-1 medications like Byetta are increasingly transitioning to newer therapies such as Wegovy and Zepbound. Here’s how the switching process works, why dose escalation matters, and what clinicians consider when choosing between semaglutide and tirzepatide.